Monovalent rotavirus vaccine effectiveness and impact on rotavirus hospitalizations in zanzibar, Tanzania: Data from the first 3 years after introduction

Journal of Infectious Diseases

Volumn 215, Issue 2, 2017, Pages 183-191

  Abeid, Khamis Ali ^a   Jani, Bhavin ^c   Cortese, Margaret M ^d   Kamugisha, Christopher ^c   Mwenda, Jason M ^c   Pandu, Aziza Salim ^a   Msaada, Kazija Ali ^a   Mohamed, Abdallah Said ^a   Khamis, Asha Ussi ^b   Parashar, Umesh D ^d   Saleh, Abdulhamid A ^b  

^a Eye Department   (Tanzania)

^b and Children   (Tanzania)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Africa; Rotavirus; rotavirus vaccine; Tanzania; Vaccine effectiveness; Vaccine impact; Zanzibar

Indexed keywords

LIVE VACCINE; RIX4414 VACCINE; ROTAVIRUS VACCINE;

FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; ROTAVIRUS INFECTION; TANZANIA; TREATMENT OUTCOME;

CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TANZANIA; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 85021857766     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw524     Document Type: Article

References (23)

1. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
2. Cunliffe NA, Witte D, Ngwira BM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial. Vaccine 2012; 30(suppl 1): A36-43.
3. Madhi SA, Kirsten M, Louw C, et al. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial. Vaccine 2012; 30(suppl 1):A44-51.
4. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD; WHOcoordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-Associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-Analysis. Lancet Infect Dis 2012; 12:136-41.
5. National Bureau of Statistics. 2015 Tanzania in figures. http://www.nbs.go.tz/. Accessed 16 August 2016.
6. National Bureau of Statistics and Office of Chief Government Statistician. Mortality and health, July 2015. http://www.nbs.go.tz/. Accessed 16 August 2016.
7. World Health Organization. Generic protocol for monitoring impact of rotavirus vaccination on rotavirus disease burden and viral strains. 2009. www.who.int/nuvi/rotavirus/WHO-IVB-08.16-eng.pdf. Accessed 16 August 2016.
8. Gouvea V, Glass RI, Woods PA, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-82.
9. Iturriza Gomara M, Kang G, Mammen A, et al. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol 2004; 42:2541-7.
10. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365-73.
11. Ruuska T, Vesikari T. A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2 years. Acta Paediatr Scand 1991; 5:500-7.
12. Gastañaduy PA, Steenhoff AP, Mokomane M, et al. Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: A multisite prospective case-control study. Clin Infect Dis 2016; 62(suppl 2): S161-7.
13. Groome MJ, Page N, Cortese MM, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: A case-control study [published correction occurs in Lancet Infect Dis 2014; 14:1040]. Lancet Infect Dis 2014; 14:1096-104.
14. Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: An observational and casecontrol study. Lancet Infect Dis 2015; 15:422-8.
15. Beres LK, Tate JE, Njobvu L, et al. A preliminary assessment of rotavirus vaccine effectiveness in Zambia. Clin Infect Dis 2016; 62(suppl 2):S175-82.
16. Armah G, Pringle K, Enweronu-Laryea CC, et al. Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana. Clin Infect Dis 2016; 62(suppl 2):S200-7.
17. Tate JE, Parashar UD. Rotavirus vaccines in routine use. Clin Infect Dis 2014; 59:1291-301.
18. Bar-Zeev N, Jere KC, Bennett A, et al. Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses. Clin Infect Dis 2016; 62 (suppl 2):S213-9.
19. Yen C, Tate JE, Hyde TB, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother 2014; 10(6):1436-48.
20. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011; 53:245-53.
21. Prelog M, Gorth P, Zwazl I, et al. Universal mass vaccination against rotavirus: indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination. J Infect Dis 2016; 214:546-55.
22. Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30(suppl 1):S30-4.
23. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30( suppl 1):S6-S10.